These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Staging lung carcinoma with a Tc-99m labeled monoclonal antibody. Vansant JP, Johnson DH, O'Donnell DM, Stewart JR, Sonin AH, McCook BM, Powers TA, Salk DJ, Frist WH, Sandler MP. Clin Nucl Med; 1992 Jun; 17(6):431-8. PubMed ID: 1319860 [Abstract] [Full Text] [Related]
3. Detection and staging of small cell lung carcinoma with a technetium-labeled monoclonal antibody. A comparison with standard staging methods. Balaban EP, Walker BS, Cox JV, Bordlee RP, Salk D, Abrams PG, Sheehan RG, Frenkel EP. Clin Nucl Med; 1992 Jun; 17(6):439-45. PubMed ID: 1319861 [Abstract] [Full Text] [Related]
4. NR-LU-10 monoclonal antibody scanning. A helpful new adjunct to computed tomography in evaluating non-small-cell lung cancer. Rusch V, Macapinlac H, Heelan R, Kramer E, Larson S, McCormack P, Burt M, Martini N, Ginsberg R. J Thorac Cardiovasc Surg; 1993 Aug; 106(2):200-4. PubMed ID: 8393504 [Abstract] [Full Text] [Related]
5. Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary results. Kramer EL, Noz ME, Liebes L, Murthy S, Tiu S, Goldenberg DM. Cancer; 1994 Feb 01; 73(3 Suppl):890-5. PubMed ID: 8306275 [Abstract] [Full Text] [Related]
6. Radioimmunoimaging of non-small cell lung cancer with 111In- and 99mTc-labeled monoclonal anti-CEA-antibodies. Kairemo KJ, Aronen HJ, Liewendahl K, Paavonen T, Heikkonen JJ, Virkkunen P, Mäki-Hokkonen H, Karonen SL, Brownell AL, Mäntylä MJ. Acta Oncol; 1993 Feb 01; 32(7-8):771-8. PubMed ID: 8305225 [Abstract] [Full Text] [Related]
7. Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies. Friedman S, Sullivan K, Salk D, Nelp WB, Griep RJ, Johnson DH, Blend MJ, Aye R, Suppers V, Abrams PG. Hematol Oncol Clin North Am; 1990 Dec 01; 4(6):1069-78. PubMed ID: 1962776 [Abstract] [Full Text] [Related]
8. In-111 octreotide imaging in staging of small cell lung cancer. Hochstenbag MM, Heidendal GA, Wouters EF, ten Velde GP. Clin Nucl Med; 1997 Dec 01; 22(12):811-6. PubMed ID: 9408640 [Abstract] [Full Text] [Related]
9. Technetium-99m monoclonal antibody fragment (Fab) scintigraphy in the evaluation of small cell lung cancer: a preliminary report. Morris JF, Krishnamurthy S, Antonovic R, Duncan C, Turner FE, Krishnamurthy GT. Int J Rad Appl Instrum B; 1991 Dec 01; 18(6):613-20. PubMed ID: 1660451 [Abstract] [Full Text] [Related]
10. Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma. Balaban EP, Walker BS, Cox JV, Sein AA, Abrams PG, Salk D, Sheehan RG, Frenkel EP. Clin Nucl Med; 1991 Oct 01; 16(10):732-6. PubMed ID: 1660386 [Abstract] [Full Text] [Related]
11. The value of octreotide scintigraphy in patients with lung cancer. Kwekkeboom DJ, Kho GS, Lamberts SW, Reubi JC, Laissue JA, Krenning EP. Eur J Nucl Med; 1994 Oct 01; 21(10):1106-13. PubMed ID: 7828621 [Abstract] [Full Text] [Related]
12. Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. Vuillez JP, Moro D, Brichon PY, Rouvier E, Brambilla E, Barbet J, Peltier P, Meyer P, Sarrazin R, Brambilla C. J Nucl Med; 1997 Apr 01; 38(4):507-11. PubMed ID: 9098191 [Abstract] [Full Text] [Related]
13. Evaluation of pentavalent Tc-99m DMSA scintigraphy in small cell and nonsmall cell lung cancers. Atasever T, Gündoğdu C, Vural G, Kapucu LO, Karalezli A, Unlü M. Nuklearmedizin; 1997 Oct 01; 36(7):223-7. PubMed ID: 9394361 [Abstract] [Full Text] [Related]
14. Immunoscintigraphy of small-cell lung cancer: a study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations. Macmillan CH, Perkins AC, Wastie ML, Leach IH, Morgan DA. Br J Cancer; 1993 Jun 01; 67(6):1391-4. PubMed ID: 8390288 [Abstract] [Full Text] [Related]
15. Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. Chaudhry A, Carrasquillo JA, Avis IL, Shuke N, Reynolds JC, Bartholomew R, Larson SM, Cuttitta F, Johnson BE, Mulshine JL. Clin Cancer Res; 1999 Nov 01; 5(11):3385-93. PubMed ID: 10589749 [Abstract] [Full Text] [Related]
16. Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma. Vuillez JP, Moro D, Brambilla E, Brichon PY, Ferretti G, Saccavini JC, Brambilla C. Eur J Cancer; 1994 Nov 01; 30A(8):1089-92. PubMed ID: 7654435 [Abstract] [Full Text] [Related]
17. Comparison of FDG-PET findings of brain metastasis from non-small-cell lung cancer and small-cell lung cancer. Lee HY, Chung JK, Jeong JM, Lee DS, Kim DG, Jung HW, Lee MC. Ann Nucl Med; 2008 May 01; 22(4):281-6. PubMed ID: 18535878 [Abstract] [Full Text] [Related]
18. Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma. Kirsch CM, von Pawel J, Grau I, Tatsch K. Eur J Nucl Med; 1994 Dec 01; 21(12):1318-25. PubMed ID: 7875170 [Abstract] [Full Text] [Related]
19. Radioimmunodetection of human small cell lung carcinoma xenografts in the nude rat using 111in-labelled monoclonal antibody MOC-31. de Jonge MW, Kosterink JG, Bin YY, Bulte JW, Kengen RA, Piers DA, The TH, de Leij L. Eur J Cancer; 1993 Dec 01; 29A(13):1885-90. PubMed ID: 8260247 [Abstract] [Full Text] [Related]
20. Pharmacokinetics and scintigraphy of indium-111-DTPA-MOC-31 in small-cell lung carcinoma. Kosterink JG, de Jonge MW, Smit EF, Piers DA, Kengen RA, Postmus PE, Shochat D, Groen HJ, The HT, de Leij L. J Nucl Med; 1995 Dec 01; 36(12):2356-62. PubMed ID: 8523132 [Abstract] [Full Text] [Related] Page: [Next] [New Search]